FDA orphan drug designation: treatment of homocystinuria due to genetic defects of intracellular cobalamin processing
All entries for: Meta Healthcare Ltd
September 26, 2025
Meta Healthcare Ltd
Orphan Drug Designation
FDA orphan drug designation: treatment of methylmalonic acidemia due to genetic defects of intracellular cobalamin processing
Disease Area: Rare Diseases
